Psychostimulants act within the prefrontal cortex to improve cognitive function

Biological Psychiatry

Volumn 72, Issue 3, 2012, Pages 221-227

  Spencer, Robert C ^a   Klein, Raymond M ^a   Berridge, Craig W ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

ADHD; cognition; executive function; psychostimulants; Ritalin; striatum

Indexed keywords

METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CINGULATE; ARTICLE; COGNITION; CONTROLLED STUDY; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; TASK PERFORMANCE; WORKING MEMORY;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; CORPUS STRIATUM; ELECTRODES, IMPLANTED; GABA AGONISTS; MALE; MAZE LEARNING; METHYLPHENIDATE; MICROINJECTIONS; MUSCIMOL; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; STEREOTAXIC TECHNIQUES; STILBAMIDINES; STIMULATION, CHEMICAL;

EID: 84863723287     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2011.12.002     Document Type: Article

References (52)

1. Greenhill LL (2001): Clinical effects of stimulant medication in ADHD. In: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. New York: Oxford University Press, 31-71.
2. Bush G, Valera EM, Seidman LJ (2005): Functional neuroimaging of attention-deficit/hyperactivity disorder: A review and suggested future directions. Biol Psychiatry 57:1273-1284. (Pubitemid 40798546)
3. Mehta MA, Goodyer IM, Sahakian BJ (2004): Methylphenidate improves working memory and set-shifting in AD/HD: Relationships to baseline memory capacity. J Child Psychol Psychiatry 45:293-305. (Pubitemid 38240276)
4. Castellanos FX, Tannock R (2002): Neuroscience of attention-deficit/ hyperactivity disorder: The search for endophenotypes. Nat Rev Neurosci 3:617-628. (Pubitemid 135706670)
5. Shaw P, Lalonde F, Lepage C, Rabin C, Eckstrand K, Sharp W, et al. (2009): Development of cortical asymmetry in typically developing children and its disruption in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 66:888-896.
6. Mehta MA, Sahakian BJ, Robbins TW (2001): Comparative psychopharmacology of methylphenidate and related drugs in human volunteers, patients with ADHD, and experimental animals. In: Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. New York: Oxford University Press, 303-331.
7. Kuczenski R, Segal DS (2002): Exposure of adolescent rats to oral methylphenidate: Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 22:7264-7271.
8. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AF, Kelley AE, Schmeichel B, et al. (2006): Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60:1111-1120. (Pubitemid 44647216)
9. Gamo NJ, Wang M, Arnsten AFT (2010): Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry 49:1011-1023.
10. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, et al. (2008): Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. J. Am Acad Child Adolesc Psychiatry 47:21-31.
11. Dickstein SG, Bannon K, Castellanos FX, Milham MP (2006): The neural correlates of attention deficit hyperactivity disorder: An ALE meta-analysis. J Child Psychol Psychiatry 47:1051-1062. (Pubitemid 44642434)
12. Devilbiss DM, BerridgeCW(2008): Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness. Biol Psychiatry 64:626-635.
13. Rubia K, Overmeyer S, Taylor E, Brammer M, Williams SCR, Simmons A, Bullmore ET (1999): Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI. Am J Psychiatry 156:891-896. (Pubitemid 29260344)
14. Sheridan MA, Hinshaw S, D'EspositoM(2007): Efficiency of the prefrontal cortex during working memory in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:1357-1366. (Pubitemid 47462195)
15. Vaidya CJ, Austin G, Kirkorian G, RidlehuberHW,DesmondJE, Glover GH, Gabrieli JD (1998): Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proc Natl Acad Sci U S A 95:14494-14499. (Pubitemid 28549395)
16. Seidman LJ, Valera EM, Makris N (2005): Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry 57:1263-1272. (Pubitemid 40798545)
17. Balleine BW, Delgado MR, Hikosaka O (2007): The role of the dorsal striatum in reward and decision-making. J Neurosci 27:8161-8165. (Pubitemid 47219597)
18. Balleine BW, O'Doherty JP (2010): Human and rodent homologies in action control: Corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 35:48-69.
19. Clatworthy PL, Lewis SJG, Brichard L, Hong YT, Izquierdo D, Clark L, et al. (2009): Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci 29:4690-4696.
20. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, et al. (2002): Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications. Synapse 43:181-187. (Pubitemid 34087672)
21. Kesner RP (2000): Subregional analysis of mnemonic functions of the prefrontal cortex in the rat. Psychobiology 28:219-228.
22. Berridge CW, Devilbiss DM (2011): Psychostimulants as cognitive enhancers: The prefrontal cortex, catecholamines, and attention-deficit/ hyperactivity disorder. Biol Psychiatry 69:e101-e111.
23. Berridge CW, Shumsky JS, Andrzejewski ME, McGaughy JA, Spencer RC, Devilbiss DM, Waterhouse BD (2011): Differential sensitivity to psychostimulants across prefrontal cognitive tasks: Differential involvement of noradrenergic α(1)-and α(2)-receptors [published online ahead of print September 2]. Biol Psychiatry.
24. Dalley JW, Cardinal RN, Robbins TW (2004): Prefrontal executive and cognitive functions in rodents: Neural and neurochemical substrates. Neurosci Biobehav Rev 28:771-784. (Pubitemid 39535871)
25. Vertes RP (2004): Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 51:32-58.
26. Ragozzino ME (2007): The contribution of the medial prefrontal cortex, orbitofrontal cortex, and dorsomedial striatum to behavioral flexibility. Ann N Y Acad Sci 1121:355-375.
27. Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, PennartzCM (2004): Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 27:468-474. (Pubitemid 38951039)
28. España RA, Reis KM, Valentino RJ, Berridge CW (2005): Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. J Comp Neurol 481:160-178. (Pubitemid 39587437)
29. Arnsten AF, Dudley AG (2005): Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav Brain Funct 1:2.
30. Vertes RP (2006): Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 142:1-20.
31. Seidman LJ, Valera EM, Makris N, Monuteaux MC, Boriel DL, Kelkar K, et al. (2006): Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiatry 60:1071-1080. (Pubitemid 44754859)
32. Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, et al. (1999): Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the counting Stroop. Biol Psychiatry 45:1542-1552. (Pubitemid 29292830)
33. Seamans JK, Lapish CC, Durstewitz D (2008): Comparing the prefrontal cortex of rats and primates: Insights from electrophysiology. Neurotox Res 14:249-262.
34. Arnsten AF (2006): Fundamentals of attention-deficit/hyperactivity disorder: Circuits and pathways. J Clin Psychiatry 67(suppl 8):7-12.
35. Floresco SB, Braaksma DN, PhillipsAG(1999): Involvement of the ventral pallidum in working memory tasks with or without a delay. AnnNY Acad Sci 877:711-716. (Pubitemid 29351898)
36. WangG-W, Cai J-X (2006): Disconnection of the hippocampal-prefrontal cortical circuits impairs spatial working memory performance in rats. Behav Brain Res 175:329-336. (Pubitemid 44750237)
37. Robbins TW, Arnsten AFT (2009): The neuropsychopharmacology of fronto-executive function: Monoaminergic modulation. Annu Rev Neurosci 32:267-287.
38. Arnsten AF, Li BM (2005): Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions. Biol Psychiatry 57:1377-1384. (Pubitemid 40798558)
39. Vijayraghavan S, Wang M, Birnbaum SG, Williams GV, Arnsten AF (2007): Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat Neurosci 10:376-384.
40. Arnsten AF, Mathew R, Ubriani R, Taylor JR, Li BM (1999): Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol Psychiatry 45:26-31. (Pubitemid 29049201)
41. Arnsten AF, Steere JC, Hunt RD (1996): The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53:448-455. (Pubitemid 26149234)
42. Arnsten AF (2000): Through the looking glass: Differential noradrenergic modulation of prefrontal cortical function. Neural Plast 7:133-146.
43. Arnsten AF (2007): Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge":Arational bridge between genetics and the symptoms of mental illness. Cereb Cortex 17(suppl 1):i6-i15.
44. Birnbaum SG, Yuan PX, Wang M, Vijayraghavan S, Bloom AK, Davis DJ, et al. (2004): Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 306:882-884. (Pubitemid 39446999)
45. Cardinal RN, Pennicott DR, Sugathapala CL, Robbins TW, Everitt BJ (2001): Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 292:2499-2501. (Pubitemid 32601663)
46. Volkow ND, Wang G-J, Newcorn JH, Kollins SH, Wigal TL, Telang F, et al. (2011): Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Mol Psychiatry 16:1147-1154.
47. Volkow ND, Wang G-J, Kollins SH, Wigal TL, Newcorn JH, Telang F, et al. (2009): Evaluating dopamine reward pathway in ADHD. JAMA 302:1084-1091.
48. Scheres A, Milham MP, Knutson B, Castellanos FX (2007): Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/ hyperactivity disorder. Biol Psychiatry 61:720-724. (Pubitemid 46328856)
49. Dodds CM, Muller U, Clark L, van Loon A, Cools R, Robbins TW (2008): Methylphenidate has differential effects on blood oxygenation leveldependent signal related to cognitive subprocesses of reversal learning. J Neurosci 28:5976-5982.
50. Mair RG, Koch JK, Newman JB, Howard JR, Burk JA (2002): A double dissociation within striatum between serial reaction time and radial maze delayed nonmatching performance in rats. J Neurosci 22:6756-6765. (Pubitemid 35386432)
51. Seamans JK, Phillips AG (1994): Selective memory impairments produced by transient lidocaine-induced lesions of the nucleus accumbens in rats. Behav Neurosci 108:456-468. (Pubitemid 24200053)
52. Swanson LW (1992): Brain Maps: Structure of the Rat Brain. Amsterdam: Elsevier.